FDA threatens to revoke Immucor's reagents license - Atlanta Business Chronicle:

http://www.wateresources.org/2008/10/06/upgrade-of-water-supply-under-way/
The Norcross-based company, which makews and supplies blood-reagent systems to the bloodf transfusion industry, did not immediately returbn a callfor comment. The news sent Immucor’ stocj into a swoon. It fell more than $2.30, or nearlu 15 percent, by mid-afternoon Friday. The , in an administrative actionj based on an early January 2009 issued a notice of intent torevoke Immucor’z biologics license with respect to its Reageng Red Blood Cells and Anti-r (Monoclonal) Blood Grouping Reagent product, the company said in a statement.
The FDA has not ordererd the recall of any ofthe company's Immucor, which has 10 days to respond to the FDA, said it spenft more than $2 million duringb fiscal 2009 on improving quality systems and it expectds to spend up to $4.5 milliojn in fiscal 2010. In late Immucor said it got a subpoena fromthe . The subpoenaz asked for documents for the periodbeginninv Sept. 1, 2000 through the present, pertaining to an investigation of possible violations of the federal criminakl antitrust laws in the blood reagents In 2007, the company paid a $30,000p settlement to the related to chargees of improper payments Immucor's Italian subsidiary allegedly made to an Italianh physician.
That same year, the asked the companyu for certain documents and information about threre acquisitions the company made from 1996 to 1999 regarding producytpricing activities.